{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T00:35:37Z","timestamp":1715646937815},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,5,13]]},"DOI":"10.7759\/cureus.60186","type":"journal-article","created":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T11:23:04Z","timestamp":1715599384000},"source":"Crossref","is-referenced-by-count":0,"title":["Lady With the Blue Hair: An Atypical Cause of Myasthenic Crisis"],"prefix":"10.7759","author":[{"given":"Jomaries O","family":"Gomez Rosado","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teresa","family":"Perez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kellie N","family":"Fusco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faryal","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tianna L","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taylor A","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hoan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tye","family":"Barber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Myasthenia gravis. (2023). Accessed. March 31, 2024: https:\/\/www.ninds.nih.gov\/health-information\/disorders\/myasthenia-gravis."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1136\/pgmj.2004.018903","article-title":"Update on myasthenia gravis","volume":"80","author":"Thanvi BR","year":"2004","unstructured":"Thanvi BR, Lo TC. Update on myasthenia gravis. Postgrad Med J. 2004, 80:690-700. 10.1136\/pgmj.2004.018903","journal-title":"Postgrad Med J"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10112235","article-title":"Myasthenia gravis: epidemiology, pathophysiology and clinical manifestations","volume":"10","author":"Dresser L","year":"2021","unstructured":"Dresser L, Wlodarski R, Rezania K, Soliven B. Myasthenia gravis: epidemiology, pathophysiology and clinical manifestations. J Clin Med. 2021, 10:2235. 10.3390\/jcm10112235","journal-title":"J Clin Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1186\/1752-1947-4-393","article-title":"Emotional stress as a trigger of myasthenic crisis and concomitant takotsubo cardiomyopathy: a case report","volume":"4","author":"Beydoun SR","year":"2010","unstructured":"Beydoun SR, Wang J, Levine RL, Farvid A. Emotional stress as a trigger of myasthenic crisis and concomitant takotsubo cardiomyopathy: a case report. J Med Case Rep. 2010, 4:393. 10.1186\/1752-1947-4-393","journal-title":"J Med Case Rep"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.ncl.2018.01.002","article-title":"Generalized myasthenia gravis: classification, clinical presentation, natural history, and epidemiology","volume":"36","author":"Hehir MK","year":"2018","unstructured":"Hehir MK, Silvestri NJ. Generalized myasthenia gravis: classification, clinical presentation, natural history, and epidemiology. Neurol Clin. 2018, 36:253-60. 10.1016\/j.ncl.2018.01.002","journal-title":"Neurol Clin"},{"key":"ref6","unstructured":"Overview of the treatment of myasthenia gravis. (2024). Accessed. March 31, 2024: https:\/\/www.uptodate.com\/contents\/overview-of-the-treatment-of-myasthenia-gravis."},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1177\/1941875210382918","article-title":"Myasthenic crisis","volume":"1","author":"Wendell LC","year":"2011","unstructured":"Wendell LC, Levine JM. Myasthenic crisis. Neurohospitalist. 2011, 1:16-22. 10.1177\/1941875210382918","journal-title":"Neurohospitalist"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcn152","article-title":"Myasthenic crisis","volume":"102","author":"Chaudhuri A","year":"2009","unstructured":"Chaudhuri A, Behan PO. Myasthenic crisis. QJM. 2009, 102:97-107. 10.1093\/qjmed\/hcn152","journal-title":"QJM"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.4103\/0028-3886.15050","article-title":"Myasthenic crisis: clinical features, complications and mortality","volume":"53","author":"Murthy JM","year":"2005","unstructured":"Murthy JM, Meena AK, Chowdary GV, Naryanan JT. Myasthenic crisis: clinical features, complications and mortality. Neurol India. 2005, 53:37-40. 10.4103\/0028-3886.15050","journal-title":"Neurol India"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.3390\/jcm10071537","article-title":"Drugs that induce or cause deterioration of myasthenia gravis: an update","volume":"10","author":"Sheikh S","year":"2021","unstructured":"Sheikh S, Alvi U, Soliven B, Rezania K. Drugs that induce or cause deterioration of myasthenia gravis: an update. J Clin Med. 2021, 10:1537. 10.3390\/jcm10071537","journal-title":"J Clin Med"},{"key":"ref11","unstructured":"Reregistration eligibility decision (RED) methylisothiazolinone. (1998). Accessed. March 31, 2024: https:\/\/archive.epa.gov\/pesticides\/reregistration\/web\/pdf\/3092.pdf."},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2133.2011.10523.x","article-title":"Methylisothiazolinone contact allergy: a review","volume":"165","author":"Lundov MD","year":"2011","unstructured":"Lundov MD, Krongaard T, Menn\u00e9 TL, Johansen JD. Methylisothiazolinone contact allergy: a review. Br J Dermatol. 2011, 165:1178-82. 10.1111\/j.1365-2133.2011.10523.x","journal-title":"Br J Dermatol"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1097\/DER.0b013e31827edc73","article-title":"Methylisothiazolinone","volume":"24","author":"Castanedo-Tardana MP","year":"2013","unstructured":"Castanedo-Tardana MP, Zug KA. Methylisothiazolinone. Dermatitis. 2013, 24:2-6. 10.1097\/DER.0b013e31827edc73","journal-title":"Dermatitis"},{"key":"ref14","unstructured":"Commission Regulation (EU) no 1003\/2014 of 18 September 2014 amending Annex V to Regulation (EC) no 1223\/2009 of the European Parliament and of the Council on Cosmetic Products. (2014). Accessed. March 31, 2024: https:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/PDF\/?uri=CELEX:32014R1003."},{"key":"ref15","unstructured":"Commission Regulation (EU) 2016\/1198 of 22 July 2016 amending Annex V to Regulation (EC) no 1223\/2009 of the European Parliament and of the Council on Cosmetic Products. (2016). Accessed. March 31, 2024: https:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/PDF\/?uri=CELEX:32016R1198&from=PT."},{"key":"ref16","unstructured":"Commission Regulation (EU) 2017\/1224 of 6 July 2017 amending Annex V to Regulation (EC) no 1223\/2009 of the European Parliament and of the Council on Cosmetic Products. (2017). Accessed. March 31, 2024: https:\/\/eur-lex.europa.eu\/legal-content\/EN\/TXT\/?uri=CELEX%3A32017R1224."},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1503\/cmaj.109-4570","article-title":"Ubiquitous preservative blamed for rash of skin allergies","volume":"185","author":"Cross C","year":"2013","unstructured":"Cross C. Ubiquitous preservative blamed for rash of skin allergies. CMAJ. 2013, 185:E712. 10.1503\/cmaj.109-4570","journal-title":"CMAJ"},{"key":"ref18","unstructured":"Methylisothiazolinone. (2017). Accessed. March 31, 2024: https:\/\/www.tga.gov.au\/resources\/publication\/scheduling-decisions-interim\/scheduling-delegates-interim-decisions-and-...."},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3390\/molecules25225284","article-title":"Characteristics of exposure to chloromethylisothiazolinone (CMIT) and methylisothiazolinone (MIT) among humidifier disinfectant-associated lung injury (HDLI) patients in South Korea","volume":"25","author":"Park DU","year":"2020","unstructured":"Park DU, Park SK, Kim J, et al.. Characteristics of exposure to chloromethylisothiazolinone (CMIT) and methylisothiazolinone (MIT) among humidifier disinfectant-associated lung injury (HDLI) patients in South Korea. Molecules. 2020, 25:5284. 10.3390\/molecules25225284","journal-title":"Molecules"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.aquatox.2017.08.013","article-title":"Methylisothiazolinone toxicity and inhibition of wound healing and regeneration in planaria","volume":"191","author":"Van Huizen AV","year":"2017","unstructured":"Van Huizen AV, Tseng AS, Beane WS. Methylisothiazolinone toxicity and inhibition of wound healing and regeneration in planaria. Aquat Toxicol. 2017, 191:226-35. 10.1016\/j.aquatox.2017.08.013","journal-title":"Aquat Toxicol"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/246211-lady-with-the-blue-hair-an-atypical-cause-of-myasthenic-crisis","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T11:23:11Z","timestamp":1715599391000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/246211-lady-with-the-blue-hair-an-atypical-cause-of-myasthenic-crisis"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,5,13]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.60186","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,5,13]]}}}